Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Sets Board Meeting to Approve Nine-Month ResultsTip Ranks·Oct 15, 2026 at 10:10 AM01349-1.98%688505-1.20%
Shanghai Fudan Zhangjiang Bio Pharmaceutical Places RMB210 Million in SPD Bank Structured DepositTip Ranks·Oct 11, 2026 at 10:37 AM01349-1.98%688505-1.20%
Fudan Zhangjiang Invests RMB150 Million in Low-Risk Bank of China Structured DepositTip Ranks·Oct 9, 2026 at 09:39 AM01349-1.98%688505-1.20%
Fudan-Zhangjiang Clarifies Connected Transactions in 2025 Annual ReportTip Ranks·Sep 24, 2026 at 09:37 AM01349-1.98%688505-1.20%
Hong Kong's Divergent Paths: AI Supply Chain Windfalls and Real Estate ReckoningsGlobal Report·Sep 22, 2026 at 10:14 AM02012-2.98%01349-1.98%
Shanghai Fudan-Zhangjiang FY26 H1 net profit attributable to shareholders more than doubles to RMB 36.89 million; revenue falls 4.58% to RMB 372.23 millionPUBT·Aug 28, 2026 at 09:02 AM01349-1.98%688505-1.20%
Fudan Zhangjiang Boosts Yield on Idle Cash With RMB210 Million SPD Bank DepositTip Ranks·Jul 2, 2026 at 09:40 AM688505-1.20%600000-1.29%
Fudan-Zhangjiang Bio-Pharma Adopts Performance-Linked Pay Rules for Top ExecutivesTip Ranks·May 28, 2026 at 11:57 AM688505-1.20%01349-1.98%
Fudan Zhangjiang Invests RMB210 Million in Low-Risk SPD Bank Structured DepositTip Ranks·Apr 7, 2026 at 11:18 AM688505-1.20%600000-1.29%
"Performance" Shanghai Fudan's annual net profit is 232 million RMB, a decrease of 59.4%, with a dividend of 0.58 RMB per 10 sharesAASTOCKS·Mar 29, 2026 at 12:13 PM688505-1.20%01349-1.98%
"Profit Warning" Fudan-Zhangjiang estimates a full-year loss of 120 million to 180 million RMBAASTOCKS·Feb 1, 2026 at 10:39 AM159316-2.39%159837-1.07%
Fudan-Zhangjiang Deploys RMB110 Million in Low-Risk Structured DepositsTip Ranks·Jan 7, 2026 at 09:39 AM01349-1.98%688505-1.20%
Fudan-Zhangjiang Places RMB150 Million in Low-Risk Bank of China Structured DepositTip Ranks·Jan 6, 2026 at 10:08 AM01349-1.98%688505-1.20%